subscribe
 

Join Lonza’s free webinar on convenient and efficient non-viral iPSC generation

12th June 2013


Recent advances have shown that various adult cell types can be reprogrammed to a pluripotent state by introduction of stem cell-associated genes using transfection.

The resulting induced pluripotent stem cells (iPSCs) appear to be phenotypically and functionally equivalent to human embryonic stem cells. Lonza is hosting a free webinar entitled “Convenient and Efficient Non-viral iPSC Generation” to teach about Nucleofection™, a proven transfection technology for iPSC generation. Two 45-minute sessions will be followed by live Q&As. The first webinar is scheduled for 18 June 2013 at 10 AM CEST (Berlin). The second session will be held on 19 June 2013 at 2 PM EDT (New York). For more details, please visit www.lonza.com/webinar4.
 
The ability of iPSCs to self-renew in culture and their potential to differentiate into specific cell types makes them a powerful research tool. Presenters will outline the basics of the Nucleofector™ Technology and discuss the use of Nucleofection™ for the generation of iPSC derived from various cell types, such as fibroblast and blood cells, as well as the transfection of iPSC.
 
All those interested, but unable to join the webinar, please visit Lonza’s transfection page on www.lonza.com/ipsc for more information.
 
Professionals are invited to attend the free webinar by registering for their preferred date:

    •    Tuesday, 18 June 2013 – 10 AM CEST (Berlin) / 9 AM BST (London) / 5 PM JST (Tokyo) Speaker: Dr. Claudia Schwartz, Scientific Support Specialist at Lonza Cologne GmbH

    •    Wednesday, 19 June 2013 – 2 PM EDT (New York) / 11 AM PDT (Los Angeles) Speaker: Sean Fuerst, Scientific Support Specialist at Lonza Walkersville Inc.

About Lonza Pharma – Bioscience
Lonza provides the pharma market with the tools life science researchers use to develop and test therapeutics, from basic research through to final product release. Lonza’s bioscience products and services range from cell culture and discovery technologies for research, to quality control tests and software to ensure product quality. Lonza Pharma – Bioscience serves research customers worldwide in pharmaceutical, biopharmaceutical, biotechnology and personal care companies, as well as academic and government research institutions. The company delivers physiologically relevant cell biology solutions, biomarker discovery services, technologies to understand compound action and complete solutions for rapid microbiology. Primary brands include BioWhittaker™, Clonetics™, FlashGel™, MetaPhor™, MycoAlert™, Nucleofection&t rade;, NuSieve™, PAGEr™, Poietics™ and SeaKem®.
 





Subscribe

Subscribe



Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe